Pictet Asset Management Portfolio holdings
AUM
$98.3B
1-Year Return
21%
This Quarter Return
+6.99%
1 Year Return
+21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$90.9B
AUM Growth
+$3.61B
(+4.1%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-1.23%
Top 10 Holdings %
Top 10 Hldgs %
17.44%
Holding
2,068
New
96
Increased
948
Reduced
550
Closed
50
Top Buys
| 1 |
SW
Smurfit Westrock plc
SW
|
+$256M |
| 2 |
Lam Research
LRCX
|
+$256M |
| 3 |
HubSpot
HUBS
|
+$185M |
| 4 |
Micron Technology
MU
|
+$166M |
| 5 |
Gilead Sciences
GILD
|
+$141M |
Top Sells
| 1 |
Autodesk
ADSK
|
+$272M |
| 2 |
NextEra Energy, Inc.
NEE
|
+$165M |
| 3 |
Trane Technologies
TT
|
+$164M |
| 4 |
ON Semiconductor
ON
|
+$160M |
| 5 |
PTC
PTC
|
+$152M |
Sector Composition
| 1 | Technology | 30.79% |
| 2 | Industrials | 17.87% |
| 3 | Healthcare | 13.8% |
| 4 | Consumer Discretionary | 8% |
| 5 | Utilities | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
General Mills
GIS
$26.8B
| $25.3M | 0.03% |
342,309
-332
| -0.1% | -$24.5K |
|
427
Copart
CPRT
$47.1B
| $25.1M | 0.03% |
479,057
+61,823
| +15% | +$3.24M |
|
428
Northrop Grumman
NOC
$83.3B
| $25M | 0.03% |
47,415
+710
| +2% | +$375K |
|
429
Jazz Pharmaceuticals
JAZZ
$7.88B
| $25M | 0.03% |
225,215
-13,706
| -6% | -$1.52M |
|
430
Alkermes
ALKS
$4.7B
| $24.9M | 0.03% |
902,719
-123,339
| -12% | -$3.4M |
|
431
Ferrovial SE
FER
$40.2B
| $24.7M | 0.03% |
574,333
-1,305
| -0.2% | -$56.2K |
|
432
iShares Gold Trust
IAU
$53.3B
| $24.7M | 0.03% |
492,500
+213,500
| +77% | +$10.7M |
|
433
Quanta Services
PWR
$56B
| $24.6M | 0.03% |
82,440
+1,165
| +1% | +$347K |
|
434
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.5B
| $24.5M | 0.03% |
262,549
+55,800
| +27% | +$5.21M |
|
435
Vital Farms
VITL
$2.11B
| $24.4M | 0.03% |
696,403
+87,188
| +14% | +$3.06M |
|
436
EOG Resources
EOG
$64.2B
| $24.4M | 0.03% |
198,386
+4,761
| +2% | +$585K |
|
437
Alibaba
BABA
$337B
| $24.3M | 0.03% |
229,411
-251,318
| -52% | -$26.7M |
|
438
Spyre Therapeutics
SYRE
$1B
| $24.3M | 0.03% |
825,706
+439,089
| +114% | +$12.9M |
|
439
Paychex
PAYX
$48.7B
| $24.2M | 0.03% |
180,641
+6,397
| +4% | +$858K |
|
440
Grifois
GRFS
$6.88B
| $24.2M | 0.03% |
2,714,985
-966,143
| -26% | -$8.6M |
|
441
89bio
ETNB
$1.27B
| $24M | 0.03% |
3,246,608
-355,977
| -10% | -$2.63M |
|
442
Kadant
KAI
$3.84B
| $24M | 0.03% |
71,006
+1,831
| +3% | +$619K |
|
443
KE Holdings
BEKE
$22.7B
| $24M | 0.03% |
1,204,377
+93,156
| +8% | +$1.85M |
|
444
iShares Global Financials ETF
IXG
$574M
| $23.9M | 0.03% |
+253,100
| New | +$23.9M |
|
445
Kinder Morgan
KMI
$58.8B
| $23.6M | 0.03% |
1,070,050
-83,202
| -7% | -$1.84M |
|
|
ONC
446
BeOne Medicines Ltd. American Depositary Shares
ONC
$38.1B
| $23.6M | 0.03% |
108,129
-702
| -0.6% | -$153K |
|
447
Brown & Brown
BRO
$31.5B
| $23.5M | 0.03% |
226,828
-11,040
| -5% | -$1.14M |
|
448
Owens Corning
OC
$13B
| $23.4M | 0.03% |
132,766
+20,578
| +18% | +$3.63M |
|
449
Chemed
CHE
$6.76B
| $23.4M | 0.03% |
38,871
+852
| +2% | +$512K |
|
450
Viridian Therapeutics
VRDN
$1.62B
| $23.3M | 0.03% |
1,025,337
+3,233
| +0.3% | +$73.6K |
|